🟢 It’s wild how a decimal point can erase billions in market cap overnight for $UNH but that’s exactly what we saw with UnitedHealth (UNH) last week.
If you’re wondering why the ticker looked like a crime scene, it all boils down to one tiny, frustrating number: 0.09%.
The “Decimal Point” Disaster
The federal government dropped the hammer by announcing they are raising payments to Medicare Advantage plans by a measly 0.09% for 2026. To put that in perspective, Wall Street was baking in a 5% jump.
When you’re the nation’s leading provider of these plans, a discrepancy that large isn’t just a rounding error, it’s a fundamental shift in the business model. The market reacted accordingly, sending the stock tumbling 20% in a classic “sell first, ask questions later” panic.
The Strategy: Shrink to Grow?
Management didn’t exactly soothe nerves when they projected a 2% revenue decline for 2026. Their plan to navigate this involves some aggressive “portfolio pruning,” which sounds corporate but actually means dropping 1 million members and offloading unprofitable Medicare Advantage participants.
Market Exits: Walking away from certain Medicaid states where the math simply doesn’t work anymore.
On the surface, “losing a million customers” sounds like a disaster. But here is the part that I think the “doom-and-gloom” crowd is completely missing: efficiency over scale.
Why the Math Actually Works
Despite the revenue dip, UnitedHealth is still projecting Adjusted EPS to rise by 9% in 2026. Think about that for a second. We are looking at a company that is:
-Actively purging its least profitable segments.
-High-grading its remaining member base.
-Still growing the bottom line by nearly double digits.
The Bottom Line: Right now, UNH is trading at roughly 15x forward earnings. For a market leader that’s successfully protecting its margins during a regulatory squeeze, that feels less like a value trap and more like a massive overreaction.
Wall Street is hyper-focused on the shrinking top line, but the bottom line tells a much more resilient story and it’s going to take time for the ship to right itself. Pushing out my 2026 expectations to 2027 for a recovery. It’s a good job I’m patient!
My plan:
Hold my position and add if I get a substantially lower entry price to average down into.
The so called “Smart Money” seems to agree with this take. They’ve lowered their “pie-in-the-sky” targets because of the regulatory headwinds, but they aren’t jumping ship. They see a company that is successfully pivoting to protect its margins and for once, I’m in agreement with them!
What do you think?
🟢 If you found this post interesting, please consider adding me to your watchlist or copying my portfolio.
🟢 Find Me:
I post regular charts and research updates on my Patreon: https://www.patreon.com/c/JodyKnight_TheCraftyTrader
@jodyslaney with CISI Lvl 3 Wealth & Investment Management
🟢 Disclaimer:
The views expressed above are my personal opinion and do not constitute investment or financial advice. Please remember that your capital is at risk, and past performance is not a reliable indicator of future results.
$OSCR $SPY $QQQ